Optimizing outcomes for patients with nonmetastatic pancreatic cancer

Mark J. Truty, M.D., and colleagues discuss new research improving outcomes in pancreatic cancer. The team shares updates on staging exams, optimal response assessment and novel surgical procedures for traditionally inoperable patients.

Quality liver cancer screening provides the most favorable treatment options

Sumera I. Ilyas, M.B.B.S., a gastroenterologist at Mayo Clinic Comprehensive Cancer Center, explains that potentially curative liver cancer treatments are available only for early-stage disease. Quality liver cancer screening and knowledge ...

Bladder cancer discoveries implemented in multidisciplinary teams

Bladder cancer experts at Mayo Clinic Comprehensive Cancer Center work in multidisciplinary teams to stay at the forefront of medical research and discoveries. Innovations in diagnostics, drug development, genomics, immunotherapy, surgery ...

Kidney cancer innovations and collaborations

Mayo Clinic kidney cancer experts discuss the multispecialty integrated approach they take to kidney cancer care. At Mayo Clinic Comprehensive Cancer Center, renal cancer experts draw on the best surgical, imaging, technical and pathology ...

Testicular cancer advancements and innovations

Mayo Clinic testicular cancer experts explain the methods they are using to work toward their goal of 100% cure for patients with testicular cancer. Advanced diagnosis and screening practices, collaboration in multidisciplinary teams, ...

Prostate cancer innovations move the field forward

Prostate cancer experts at Mayo Clinic Comprehensive Cancer Center work in an integrated genitourinary practice, which allows them the size and scope they need to drive this rapidly moving field forward.

Liver cancer innovations and advanced treatment options

Liver cancer specialists at Mayo Clinic Comprehensive Cancer Center offer hope to patients in the form of the highest quality therapies available. At the Cancer Center, patients with liver cancer may have access to personalized chemotherapy ...

Managing indolent lymphoma collaboratively

Mayo Clinic hematologist and oncologist Jose (J.C.) C. Villasboas Bisneto, M.D., discusses follicular lymphoma and other indolent B-cell non-Hodgkin lymphomas. He aims to collaborate with his patients' home care teams to manage this slow growing disease.

Large B-cell lymphoma: Innovative treatment and care plans

Grzegorz S. Nowakowski, M.D., hematologist and oncologist at Mayo Clinic Comprehensive Cancer Center, explains the rapid advancements made in the treatment of large B-cell lymphoma. With unprecedented access to novel agents, lymphoma clinicians ...

Innovative melanoma therapies grounded in collaborative research and practice at Mayo Clinic

Mayo Clinic's melanoma program uses the latest science and care practices. Physician-scientists collaborate on patient care, innovative research and diagnostic excellence to provide highly individualized melanoma care.

Cholangiocarcinoma discoveries and treatment approaches

Rory L. Smoot, M.D., Mayo Clinic surgical oncologist, discusses the discoveries made in the treatment of cholangiocarcinoma and other biliary tract cancers.

Trends and treatment options in colorectal liver metastases

Mayo Clinic surgical oncologist Sean P. Cleary, M.D., discusses the safe and aggressive treatment options available when colorectal cancer has metastasized to the liver.